The Elecsys pTau181 test is the second blood test cleared by the FDA this year for use in Alzheimer’s evaluation. In May, the ...
The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback